Status:
UNKNOWN
Machine Learning-based Early Clinical Warning of High-risk Patients
Lead Sponsor:
Southeast University, China
Conditions:
High-risk Patients
Risk Reduction
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Through the early warning platform for inpatients established by our hospital, the various indicators of patients collected in real time are carried out for automated intelligent evaluation and analys...
Detailed Description
Build the early warning system.
Eligibility Criteria
Inclusion
- Patients who use ECG monitoring
- Age ≥ 18 years old
- Understand and sign an informed consent form
Exclusion
- Pregnancy or lactation
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05410171
Start Date
June 1 2022
End Date
December 1 2023
Last Update
December 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, China, 210009